Global Gastrointestinal Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Gastrointestinal Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market Segment by Application
1.3.1 Global Gastrointestinal Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Gastrointestinal Drugs Market Size (2017-2028)
2.1.1 Global Gastrointestinal Drugs Revenue (2017-2028)
2.1.2 Global Gastrointestinal Drugs Sales (2017-2028)
2.2 Global Gastrointestinal Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Gastrointestinal Drugs Sales by Regions (2017-2022)
2.2.2 Global Gastrointestinal Drugs Revenue by Regions (2017-2022)
2.3 Global Gastrointestinal Drugs Market Size Forecast by Region
2.3.1 Global Gastrointestinal Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Gastrointestinal Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Gastrointestinal Drugs Regions (Countries) Ranking by Market Size
2.5 Gastrointestinal Drugs Market Dynamics
2.5.1 Gastrointestinal Drugs Market Trends
2.5.2 Gastrointestinal Drugs Market Drivers
2.5.3 Gastrointestinal Drugs Market Challenges
2.5.4 Gastrointestinal Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Gastrointestinal Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Gastrointestinal Drugs Sales in 2021
3.2 Global Top Manufacturers Gastrointestinal Drugs by Revenue
3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Gastrointestinal Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Gastrointestinal Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2021)
3.4 Global Gastrointestinal Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Gastrointestinal Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Gastrointestinal Drugs Market
3.7 Key Manufacturers Gastrointestinal Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gastrointestinal Drugs Market Size by Type
4.1 Global Gastrointestinal Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Gastrointestinal Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Gastrointestinal Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Gastrointestinal Drugs Price by Type (2017-2022)
4.2 Global Gastrointestinal Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Gastrointestinal Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Gastrointestinal Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Gastrointestinal Drugs Price Forecast by Type (2023-2028)
5 Global Gastrointestinal Drugs Market Size by Application
5.1 Global Gastrointestinal Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Gastrointestinal Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Gastrointestinal Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Gastrointestinal Drugs Price by Application (2017-2022)
5.2 Global Gastrointestinal Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Gastrointestinal Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Gastrointestinal Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Gastrointestinal Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gastrointestinal Drugs Sales Breakdown by Company
6.1.1 North America Gastrointestinal Drugs Sales by Company (2017-2022)
6.1.2 North America Gastrointestinal Drugs Revenue by Company (2017-2022)
6.2 North America Gastrointestinal Drugs Market Size by Type
6.2.1 North America Gastrointestinal Drugs Sales by Type (2017-2028)
6.2.2 North America Gastrointestinal Drugs Revenue by Type (2017-2028)
6.3 North America Gastrointestinal Drugs Market Size by Application
6.3.1 North America Gastrointestinal Drugs Sales by Application (2017-2028)
6.3.2 North America Gastrointestinal Drugs Revenue by Application (2017-2028)
6.4 North America Gastrointestinal Drugs Market Size by Country
6.4.1 North America Gastrointestinal Drugs Sales by Country (2017-2028)
6.4.2 North America Gastrointestinal Drugs Revenue by Country (2017-2028)
6.4.3 the United States
6.4.4 Canada
7 Europe
7.1 Europe Gastrointestinal Drugs Sales Breakdown by Company
7.1.1 Europe Gastrointestinal Drugs Sales by Company (2017-2022)
7.1.2 Europe Gastrointestinal Drugs Revenue by Company (2017-2022)
7.2 Europe Gastrointestinal Drugs Market Size by Type
7.2.1 Europe Gastrointestinal Drugs Sales by Type (2017-2028)
7.2.2 Europe Gastrointestinal Drugs Revenue by Type (2017-2028)
7.3 Europe Gastrointestinal Drugs Market Size by Application
7.3.1 Europe Gastrointestinal Drugs Sales by Application (2017-2028)
7.3.2 Europe Gastrointestinal Drugs Revenue by Application (2017-2028)
7.4 Europe Gastrointestinal Drugs Market Size by Country
7.4.1 Europe Gastrointestinal Drugs Sales by Country (2017-2028)
7.4.2 Europe Gastrointestinal Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Gastrointestinal Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Gastrointestinal Drugs Market Size by Type
8.2.1 Asia Pacific Gastrointestinal Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Gastrointestinal Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Gastrointestinal Drugs Market Size by Application
8.3.1 Asia Pacific Gastrointestinal Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Gastrointestinal Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Gastrointestinal Drugs Market Size by Region
8.4.1 Asia Pacific Gastrointestinal Drugs Sales by Region
8.4.2 Asia Pacific Gastrointestinal Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Gastrointestinal Drugs Sales Breakdown by Company
9.1.1 Latin America Gastrointestinal Drugs Sales by Company (2017-2022)
9.1.2 Latin America Gastrointestinal Drugs Revenue by Company (2017-2022)
9.2 Latin America Gastrointestinal Drugs Market Size by Type
9.2.1 Latin America Gastrointestinal Drugs Sales by Type (2017-2028)
9.2.2 Latin America Gastrointestinal Drugs Revenue by Type (2017-2028)
9.3 Latin America Gastrointestinal Drugs Market Size by Application
9.3.1 Latin America Gastrointestinal Drugs Sales by Application (2017-2028)
9.3.2 Latin America Gastrointestinal Drugs Revenue by Application (2017-2028)
9.4 Latin America Gastrointestinal Drugs Market Size by Country
9.4.1 Latin America Gastrointestinal Drugs Sales by Country (2017-2028)
9.4.2 Latin America Gastrointestinal Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Gastrointestinal Drugs Market Size by Type
10.2.1 Middle East and Africa Gastrointestinal Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Gastrointestinal Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Gastrointestinal Drugs Market Size by Application
10.3.1 Middle East and Africa Gastrointestinal Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Gastrointestinal Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Gastrointestinal Drugs Market Size by Country
10.4.1 Middle East and Africa Gastrointestinal Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 AstraZeneca Gastrointestinal Drugs Products and Services
11.1.5 AstraZeneca Gastrointestinal Drugs SWOT Analysis
11.1.6 AstraZeneca Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sanofi Gastrointestinal Drugs Products and Services
11.2.5 Sanofi Gastrointestinal Drugs SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Bayer Gastrointestinal Drugs Products and Services
11.3.5 Bayer Gastrointestinal Drugs SWOT Analysis
11.3.6 Bayer Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Pfizer Gastrointestinal Drugs Products and Services
11.4.5 Pfizer Gastrointestinal Drugs SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Gastrointestinal Drugs Products and Services
11.5.5 GlaxoSmithKline Gastrointestinal Drugs SWOT Analysis
11.5.6 GlaxoSmithKline Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Teva Gastrointestinal Drugs Products and Services
11.6.5 Teva Gastrointestinal Drugs SWOT Analysis
11.6.6 Teva Recent Developments
11.7 Zeria (Tillotts)
11.7.1 Zeria (Tillotts) Corporation Information
11.7.2 Zeria (Tillotts) Overview
11.7.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Zeria (Tillotts) Gastrointestinal Drugs Products and Services
11.7.5 Zeria (Tillotts) Gastrointestinal Drugs SWOT Analysis
11.7.6 Zeria (Tillotts) Recent Developments
11.8 Perrigo
11.8.1 Perrigo Corporation Information
11.8.2 Perrigo Overview
11.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Perrigo Gastrointestinal Drugs Products and Services
11.8.5 Perrigo Gastrointestinal Drugs SWOT Analysis
11.8.6 Perrigo Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Corporation Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products and Services
11.9.5 Boehringer Ingelheim Gastrointestinal Drugs SWOT Analysis
11.9.6 Boehringer Ingelheim Recent Developments
11.10 Purdue Pharma
11.10.1 Purdue Pharma Corporation Information
11.10.2 Purdue Pharma Overview
11.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Purdue Pharma Gastrointestinal Drugs Products and Services
11.10.5 Purdue Pharma Gastrointestinal Drugs SWOT Analysis
11.10.6 Purdue Pharma Recent Developments
11.11 C.B. Fleet
11.11.1 C.B. Fleet Corporation Information
11.11.2 C.B. Fleet Overview
11.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 C.B. Fleet Gastrointestinal Drugs Products and Services
11.11.5 C.B. Fleet Recent Developments
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Overview
11.12.3 Abbott Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Abbott Gastrointestinal Drugs Products and Services
11.12.5 Abbott Recent Developments
11.13 Jiangzhong
11.13.1 Jiangzhong Corporation Information
11.13.2 Jiangzhong Overview
11.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Jiangzhong Gastrointestinal Drugs Products and Services
11.13.5 Jiangzhong Recent Developments
11.14 Xian-Janssen
11.14.1 Xian-Janssen Corporation Information
11.14.2 Xian-Janssen Overview
11.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 Xian-Janssen Gastrointestinal Drugs Products and Services
11.14.5 Xian-Janssen Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Gastrointestinal Drugs Value Chain Analysis
12.2 Gastrointestinal Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gastrointestinal Drugs Production Mode & Process
12.4 Gastrointestinal Drugs Sales and Marketing
12.4.1 Gastrointestinal Drugs Sales Channels
12.4.2 Gastrointestinal Drugs Distributors
12.5 Gastrointestinal Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Prescription Gastrointestinal Drug
Table 3. Major Manufacturers of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Gastrointestinal Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Gastrointestinal Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Gastrointestinal Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Gastrointestinal Drugs Revenue Market Share by Region (2017-2022)
Table 10. Global Gastrointestinal Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Gastrointestinal Drugs Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Gastrointestinal Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Gastrointestinal Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Gastrointestinal Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Gastrointestinal Drugs Market Trends
Table 16. Gastrointestinal Drugs Market Drivers
Table 17. Gastrointestinal Drugs Market Challenges
Table 18. Gastrointestinal Drugs Market Restraints
Table 19. Global Gastrointestinal Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Gastrointestinal Drugs Sales Share by Manufacturers (2017-2022)
Table 21. Global Gastrointestinal Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Gastrointestinal Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 23. Gastrointestinal Drugs Revenue Share by Manufacturers (2017-2022)
Table 24. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2021)
Table 26. Key Manufacturers Gastrointestinal Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Gastrointestinal Drugs Plants/Factories Distribution
Table 28. Key Manufacturers Gastrointestinal Drugs Area Served
Table 29. Date of Key Manufacturers Enter into Gastrointestinal Drugs Market
Table 30. Key Manufacturers Gastrointestinal Drugs Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Gastrointestinal Drugs Sales (K Units) by Type (2017-2022)
Table 33. Global Gastrointestinal Drugs Sales Share by Type (2017-2022)
Table 34. Global Gastrointestinal Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Gastrointestinal Drugs Price (K Units) by Type (2017-2022)
Table 36. Global Gastrointestinal Drugs Sales (K Units) by Type (2023-2028)
Table 37. Global Gastrointestinal Drugs Sales Share by Type (2023-2028)
Table 38. Global Gastrointestinal Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Gastrointestinal Drugs Revenue Share by Type (2023-2028)
Table 40. Global Gastrointestinal Drugs Price (K Units) by Type (2023-2028)
Table 41. Global Gastrointestinal Drugs Sales (K Units) by Application (2017-2022)
Table 42. Global Gastrointestinal Drugs Sales Share by Application (2017-2022)
Table 43. Global Gastrointestinal Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Gastrointestinal Drugs Price (K Units) by Application (2017-2022)
Table 45. Global Gastrointestinal Drugs Sales (K Units) by Application (2023-2028)
Table 46. Global Gastrointestinal Drugs Sales Share by Application (2023-2028)
Table 47. Global Gastrointestinal Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Gastrointestinal Drugs Revenue Share by Application (2023-2028)
Table 49. Global Gastrointestinal Drugs Price (K Units) by Application (2023-2028)
Table 50. North America Gastrointestinal Drugs Sales by Company (2017-2022) & (K Units)
Table 51. North America Gastrointestinal Drugs Sales Market Share by Company (2017-2022)
Table 52. North America Gastrointestinal Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Gastrointestinal Drugs Revenue Market Share by Company (2017-2022)
Table 54. North America Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 55. North America Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 56. North America Gastrointestinal Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Gastrointestinal Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 59. North America Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 60. North America Gastrointestinal Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Gastrointestinal Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 63. North America Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 64. North America Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Gastrointestinal Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Gastrointestinal Drugs Sales by Company (2017-2022) & (K Units)
Table 67. Europe Gastrointestinal Drugs Sales Market Share by Company (2017-2022)
Table 68. Europe Gastrointestinal Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Gastrointestinal Drugs Revenue Market Share by Company (2017-2022)
Table 70. Europe Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Europe Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Europe Gastrointestinal Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Gastrointestinal Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 75. Europe Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 76. Europe Gastrointestinal Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Gastrointestinal Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 79. Europe Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 80. Europe Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Gastrointestinal Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Gastrointestinal Drugs Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Gastrointestinal Drugs Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Gastrointestinal Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Gastrointestinal Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Gastrointestinal Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Gastrointestinal Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Gastrointestinal Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Gastrointestinal Drugs Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Gastrointestinal Drugs Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Gastrointestinal Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Gastrointestinal Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Gastrointestinal Drugs Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Gastrointestinal Drugs Sales Market Share by Company (2017-2022)
Table 100. Latin America Gastrointestinal Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Gastrointestinal Drugs Revenue Market Share by Company (2017-2022)
Table 102. Latin America Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Gastrointestinal Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Gastrointestinal Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Gastrointestinal Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Gastrointestinal Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Gastrointestinal Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Gastrointestinal Drugs Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Gastrointestinal Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Gastrointestinal Drugs Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Gastrointestinal Drugs Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Gastrointestinal Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Gastrointestinal Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Gastrointestinal Drugs Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Gastrointestinal Drugs Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Gastrointestinal Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Gastrointestinal Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Gastrointestinal Drugs Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Gastrointestinal Drugs Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 130. AstraZeneca Corporation Information
Table 131. AstraZeneca Description and Overview
Table 132. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. AstraZeneca Gastrointestinal Drugs Product and Services
Table 134. AstraZeneca Gastrointestinal Drugs SWOT Analysis
Table 135. AstraZeneca Recent Developments
Table 136. Sanofi Corporation Information
Table 137. Sanofi Description and Overview
Table 138. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Sanofi Gastrointestinal Drugs Product and Services
Table 140. Sanofi Gastrointestinal Drugs SWOT Analysis
Table 141. Sanofi Recent Developments
Table 142. Bayer Corporation Information
Table 143. Bayer Description and Overview
Table 144. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Bayer Gastrointestinal Drugs Product and Services
Table 146. Bayer Gastrointestinal Drugs SWOT Analysis
Table 147. Bayer Recent Developments
Table 148. Pfizer Corporation Information
Table 149. Pfizer Description and Overview
Table 150. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Pfizer Gastrointestinal Drugs Product and Services
Table 152. Pfizer Gastrointestinal Drugs SWOT Analysis
Table 153. Pfizer Recent Developments
Table 154. GlaxoSmithKline Corporation Information
Table 155. GlaxoSmithKline Description and Overview
Table 156. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. GlaxoSmithKline Gastrointestinal Drugs Product and Services
Table 158. GlaxoSmithKline Gastrointestinal Drugs SWOT Analysis
Table 159. GlaxoSmithKline Recent Developments
Table 160. Teva Corporation Information
Table 161. Teva Description and Overview
Table 162. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. Teva Gastrointestinal Drugs Product and Services
Table 164. Teva Gastrointestinal Drugs SWOT Analysis
Table 165. Teva Recent Developments
Table 166. Zeria (Tillotts) Corporation Information
Table 167. Zeria (Tillotts) Description and Overview
Table 168. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Zeria (Tillotts) Gastrointestinal Drugs Product and Services
Table 170. Zeria (Tillotts) Gastrointestinal Drugs SWOT Analysis
Table 171. Zeria (Tillotts) Recent Developments
Table 172. Perrigo Corporation Information
Table 173. Perrigo Description and Overview
Table 174. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 175. Perrigo Gastrointestinal Drugs Product and Services
Table 176. Perrigo Gastrointestinal Drugs SWOT Analysis
Table 177. Perrigo Recent Developments
Table 178. Boehringer Ingelheim Corporation Information
Table 179. Boehringer Ingelheim Description and Overview
Table 180. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 181. Boehringer Ingelheim Gastrointestinal Drugs Product and Services
Table 182. Boehringer Ingelheim Gastrointestinal Drugs SWOT Analysis
Table 183. Boehringer Ingelheim Recent Developments
Table 184. Purdue Pharma Corporation Information
Table 185. Purdue Pharma Description and Overview
Table 186. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 187. Purdue Pharma Gastrointestinal Drugs Product and Services
Table 188. Purdue Pharma Gastrointestinal Drugs SWOT Analysis
Table 189. Purdue Pharma Recent Developments
Table 190. C.B. Fleet Corporation Information
Table 191. C.B. Fleet Description and Overview
Table 192. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Marg

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs